Literature DB >> 20681286

[Consensus on Chinese medical diagnosis and treatment of ulcerative colitis (2009)].

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20681286

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


× No keyword cloud information.
  6 in total

1.  Clinical presentation and treatment strategies for ulcerative colitis: A retrospective study of 247 inpatients.

Authors:  Yan-Cheng Dai; Ya-Li Zhang; Li-Juan Wang; Qian Guo; Kun Yang; Ren-Hao Ye; Zhi-Peng Tang
Journal:  Chin J Integr Med       Date:  2015-10-26       Impact factor: 1.978

2.  Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: A randomized controlled trial.

Authors:  Yan-Cheng Dai; Lie Zheng; Ya-Li Zhang; Xuan Chen; De-Liang Chen; Zhi-Peng Tang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 3.  The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies.

Authors:  Yu Hu; Zhen Ye; Mingquan Wu; Yingqi She; Linzhen Li; Yujie Xu; Kaihua Qin; Zhipeng Hu; Maoyi Yang; Fating Lu; Qiaobo Ye
Journal:  Front Med (Lausanne)       Date:  2021-12-13

Review 4.  The Influence of Acupuncture Parameters on Efficacy and the Possible Use of Acupuncture in Combination with or as a Substitute for Drug Therapy in Patients with Ulcerative Colitis.

Authors:  Min'an Chen; Sisi Zhao; Yu Guo; Luxi Cao; Hai Zeng; Zhuowen Lin; Shiqi Wang; Yimin Zhang; Mingmin Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-22       Impact factor: 2.629

Review 5.  Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms.

Authors:  Jing Chen; Bixin Shen; Zhengli Jiang
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

6.  Clinical Significance of High-Mobility Group Box 1 Protein (HMGB1) and Nod-Like Receptor Protein 3 (NLRP3) in Patients with Ulcerative Colitis.

Authors:  YanMin Chen; Dong Wu; LingJia Sun
Journal:  Med Sci Monit       Date:  2020-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.